Putnam Investments’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-123,800
| Closed | -$21.9M | – | 943 |
|
|
2020
Q1 | $21.9M | Sell |
123,800
-90,480
| -42% | -$17M | 0.06% | 206 |
|
|
2019
Q4 | $41M | Sell |
214,280
-10,742
| -5% | -$1.94M | 0.08% | 188 |
|
|
2019
Q3 | $37.9M | Sell |
225,022
-82,080
| -27% | -$13.4M | 0.08% | 193 |
|
|
2019
Q2 | $51.4M | Buy |
307,102
+40,291
| +15% | +$5.58M | 0.11% | 170 |
|
|
2019
Q1 | $39.1M | Buy |
266,811
+182,300
| +216% | +$26.4M | 0.09% | 181 |
|
|
2018
Q4 | $11.3M | Buy |
84,511
+30,892
| +58% | +$5.06M | 0.03% | 301 |
|
|
2018
Q3 | $10.2M | Buy |
53,619
+1,338
| +3% | +$246K | 0.02% | 388 |
|
|
2018
Q2 | $8.72M | Buy |
52,281
+27,242
| +109% | +$4.37M | 0.02% | 401 |
|
|
2018
Q1 | $4.21M | Sell |
25,039
-39,418
| -61% | -$6.61M | 0.01% | 544 |
|
|
2017
Q4 | $10.5M | Buy |
64,457
+3,418
| +6% | +$613K | 0.02% | 375 |
|
|
2017
Q3 | $12.5M | Sell |
61,039
-500
| -0.8% | -$116K | 0.03% | 347 |
|
|
2017
Q2 | $15M | Sell |
61,539
-527,682
| -90% | -$124M | 0.04% | 311 |
|
|
2017
Q1 | $141M | Sell |
589,221
-886,905
| -60% | -$207M | 0.33% | 85 |
|
|
2016
Q4 | $310M | Sell |
1,476,126
-133,160
| -8% | -$27.6M | 0.75% | 26 |
|
|
2016
Q3 | $371M | Buy |
1,609,286
+54,267
| +3% | +$13.3M | 0.89% | 25 |
|
|
2016
Q2 | $359M | Buy |
1,555,019
+192,186
| +14% | +$44.3M | 0.88% | 20 |
|
|
2016
Q1 | $365M | Sell |
1,362,833
-131,317
| -9% | -$37.6M | 0.87% | 20 |
|
|
2015
Q4 | $467M | Sell |
1,494,150
-40,812
| -3% | -$12.2M | 1.05% | 16 |
|
|
2015
Q3 | $417M | Sell |
1,534,962
-68,985
| -4% | -$21.2M | 0.93% | 16 |
|
|
2015
Q2 | $487M | Sell |
1,603,947
-51,126
| -3% | -$15.2M | 0.98% | 15 |
|
|
2015
Q1 | $493M | Sell |
1,655,073
-50,047
| -3% | -$14.3M | 0.98% | 13 |
|
|
2014
Q4 | $439M | Buy |
1,705,120
+226,153
| +15% | +$56.5M | 0.9% | 15 |
|
|
2014
Q3 | $357M | Sell |
1,478,967
-14,349
| -1% | -$3.21M | 0.76% | 25 |
|
|
2014
Q2 | $333M | Buy |
1,493,316
+47,258
| +3% | +$9.78M | 0.72% | 20 |
|
|
2014
Q1 | $298M | Sell |
1,446,058
-247,784
| -15% | -$49.1M | 0.67% | 34 |
|
|
2013
Q4 | $285M | Sell |
1,693,842
-29,055
| -2% | -$4.54M | 0.68% | 34 |
|
|
2013
Q3 | $248M | Buy |
1,722,897
+363,554
| +27% | +$48.4M | 0.66% | 33 |
|
|
2013
Q2 | $172M | Buy |
+1,359,343
| New | +$154M | 0.5% | 47 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Putnam Investments's AGN Position: Q2 2020 in Review
Putnam Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 123,800 shares — an estimated $21.9M sold.
Putnam Investments first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $493M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Putnam Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Putnam Investments sold 123,800 Allergan plc shares in Q2 2020, an estimated $21.9M.
- Putnam Investments first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Putnam Investments's Allergan plc position peaked at $493M in Q1 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Putnam Investments's 13F filing for Q2 2020, filed 14 Aug 2020.